We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Bio-Rad Announces Public Offering of $425 Million Senior Notes
News

Bio-Rad Announces Public Offering of $425 Million Senior Notes

Bio-Rad Announces Public Offering of $425 Million Senior Notes
News

Bio-Rad Announces Public Offering of $425 Million Senior Notes

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Bio-Rad Announces Public Offering of $425 Million Senior Notes"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Bio-Rad Laboratories, Inc. has announced that it intends to commence an offering, subject to market and other conditions, of $425 million aggregate principal amount of senior notes due 2020 (the "Senior Notes") in a public offering pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission.

The interest rate and other terms of the Senior Notes are to be determined by negotiations between the Company and the underwriters of the Senior Notes. The Company intends to use the proceeds from this offering, together with cash on hand, to redeem all $225 million of its outstanding 7.50% senior subordinated notes due 2013 and all $200 million of its outstanding 6.125% senior subordinated notes due 2014.

Credit Suisse Securities (USA) LLC and Goldman, Sachs & Co. are acting as joint book-running managers for the offering of the Senior Notes.
Advertisement